X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

March 31, 2016

Bloom Burton’s analyst David Martin speaks to BNN about Concordia's latest earnings

Click on the image to view the full video.

RELATED NEWS

Ian Mortimer Receives the 2026 Bloom Burton Award APOTEX Health Corp. Announces Closing of Upsized Bought Deal Secondary Offering BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded Warrants COSCIENS Acquires Nualtis Corp. Conavi Medical Corp. Announces Closing of $10M Public Offering SteriMax Announces Acquisition of Andone Pharmaceuticals, Expanding Presence in Medical Device and Veterinary Markets Helus Pharma™ Announces US$50 Million Underwritten Offering Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million

2026 BLOOM BURTON & CO | WEBSITE BY PIXELCARVE | MEMBER CIRO | MEMBER CIPF | PRIVACY POLICY | COMPLAINT | BEST EXECUTION POLICY | ACCESSIBILITY POLICY | BUSINESS CONTINUITY PLAN | LEGAL DISCLAIMER | CONFLICTS OF INTEREST